A study conducted by the University of Macau (UM) has yielded a breakthrough that is expected to markedly enhance the efficacy of cancer immunotherapy. The collaborative study was led by Prof Chen Xin from UM’s Institute of Chinese Medical Sciences and Dr Joost J Oppenheim from the National Cancer Institute in the United States. The result of this study challenges the traditional view points and proposes a new method for cancer immunotherapy. This study was highly praised by research community and was just featured in The Scientist, an influential international magazine that reports on the most exciting discoveries and innovative trends across the spectrum of life science.
A team from the State Key Laboratory of Analog and Mixed-Signal VLSI (AMS-VLSI Lab) presented their research findings at the 64th International Solid-State Circuits Conference (ISSCC) of the Institute of Electrical and Electronics Engineers(IEEE). Six papers from UM were accepted at this year’s conference, making UM one of the institutions with the most papers presented at the conference.
The State Key Laboratory of Quality Research in Chinese Medicine under the Institute of Chinese Medical Sciences and the National Cancer Institute under the United States National Institutes of Health, have made significant progress in a collaborative research project on safer and more effective treatment for cancer and autoimmune diseases. The related findings have been published in Science Signaling under Science magazine.
A paper by UM scholars was published in Lab on a Chip, a publication under the Royal Society of Chemistry in the United Kingdom. The paper proposes a new technique that can quickly identify the DNA of multiple potential pathogens causing septicemia from a single droplet. This new technique will allow medical workers to promptly identify pathogens and administer treatment in remote mountainous regions. This is yet another breakthrough in UM’s microchip research. The related system is expected to be put into production within the next two years.
A research team from UM has achieved a significant breakthrough in drug susceptibility test for cancer cell lines and human primary cancers by combining their expertise in precision medicine, microfluidic chip, and image processing. The screening method shortened the analysis process to within 24 hours, which was made possible by a cutting-edge, state-of-the-art technology developed in-house that merges biology and electronics, which laid a foundation for evidence-based drug susceptibility tests for precision cancer therapy. The work has been published in the open access journal Scientific Reports under the Nature Publishing Group.
A paper, co-authored by Prof Yuen Ka-Veng from the Department of Civil and Environmental Engineering, , and Prof Mu Heqing from the South China University of Technology, has been ranked the second most cited paper among over 120 papers published in 2015 and 2016 in Computer-Aided Civil and Infrastructure Engineering. Their study is expected to play a crucial role in the development of real-time structural health monitoring system for large infrastructure and buildings.
Prof Philip Chen, chair professor of the FST, received the 2017 Institute of Electrical and Electronics Engineers Transactions on Neural Networks and Learning Systems Outstanding Paper Award, for his first-authored paper titled ‘Adaptive Consensus Control for a Class of Nonlinear Multi-agent Time-delay Systems Using Neural Network’.